Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Dermatologic 1CNS 1Breast 1

Conditions

Neoplasm Metastasis 1Meningioma 1Glioma 1Central Nervous System Vascular Malformations 1Carcinoma, Basal Cell 1Breast Neoplasms 1Aneurysm 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Laser Speckle Contrast Imaging × Clear all
NCT01455363 2025-11-24

HPOB

Institut Curie

Phase NA Completed
12 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT06523452 2024-07-26

SIMBAR

Royal Devon and Exeter NHS Foundation Trust

Phase NA Recruiting
60 enrolled
Breast

Breast Neoplasms

NCT05028400 2022-04-12

LSCI-NSURG

Insel Gruppe AG, University Hospital Bern

Phase NA Completed
20 enrolled
CNS

Aneurysm, Glioma, Meningioma, Neoplasm Metastasis, Central Nervous System Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡